# OnCo record glutamine-mucositis-neuropathy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/glutamine-mucositis-neuropathy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "glutamine-mucositis-neuropathy" ;
  schema:name "Glutamine for mucositis and neuropathy"@en ;
  schema:description "Oral glutamine, an amino acid that gut and mouth lining cells use for fuel, may reduce the severity of mouth ulcers during head and neck chemoradiation; mucositis guidelines suggest it for that use. Intravenous glutamine in transplant patients is not recommended, and evidence for preventing nerve damage is thin."@en ;
  schema:url <https://onco.cc/technologies/glutamine-mucositis-neuropathy/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Glutamine> ;
  schema:citation <https://doi.org/10.1002/cncr.33100> ;
  onco:status "phase-2" ;
  onco:tag "complementary", "supportive-care", "evidence:moderate" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/rejuvenation/> ;
  onco:technologies <https://onco.cc/technologies/oncology-nutrition/>, <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/cipn-recovery-and-treatment/> ;
  onco:drugs <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:institutions <https://onco.cc/institutions/mascc/> ;
  onco:terms <https://onco.cc/terms/mucositis/>, <https://onco.cc/terms/peripheral-neuropathy/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-elad-cancer/> .
